RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Meridian Bioscience Stock

Meridian Bioscience Revenue 2024

Meridian Bioscience Revenue

302.36 M USD

Ticker

VIVO

ISIN

US5895841014

WKN

871583

In 2024, Meridian Bioscience's sales reached 302.36 M USD, a 2.8% difference from the 294.11 M USD sales recorded in the previous year.

The Meridian Bioscience Revenue history

YEARREVENUE (undefined USD)GROSS MARGIN (%)
2025e300.5362,68
2024e302.3662,30
2023e294.1164,04
2022333.0256,56
2021317.963,27
2020253.761,57
201920159,05
2018213.661,33
2017200.861,90
2016196.164,86
2015194.862,58
2014188.862,08
2013188.764,12
2012172.763,12
2011158.861,96
201014362,03
2009148.362,31
2008139.661,96
200712360,89
2006108.459,69
20059359,03
200479.657,41
200365.958,12

Meridian Bioscience Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Meridian Bioscience, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Meridian Bioscience from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Meridian Bioscience’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Meridian Bioscience. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Meridian Bioscience’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Meridian Bioscience’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Meridian Bioscience’s growth potential.

Meridian Bioscience Revenue, EBIT and net profit per share

DateMeridian Bioscience RevenueMeridian Bioscience EBITMeridian Bioscience Net Income
2025e300.53 M undefined22.86 M undefined18.62 M undefined
2024e302.36 M undefined32.45 M undefined26 M undefined
2023e294.11 M undefined46.97 M undefined37.03 M undefined
2022333.02 M undefined75.6 M undefined42.46 M undefined
2021317.9 M undefined101.83 M undefined71.41 M undefined
2020253.7 M undefined68 M undefined46.2 M undefined
2019201 M undefined38.9 M undefined24.4 M undefined
2018213.6 M undefined44.7 M undefined23.8 M undefined
2017200.8 M undefined44.8 M undefined21.6 M undefined
2016196.1 M undefined53.6 M undefined32.2 M undefined
2015194.8 M undefined56.1 M undefined35.5 M undefined
2014188.8 M undefined52.4 M undefined34.7 M undefined
2013188.7 M undefined57.3 M undefined38 M undefined
2012172.7 M undefined50.3 M undefined33.4 M undefined
2011158.8 M undefined41.8 M undefined26.8 M undefined
2010143 M undefined41.1 M undefined26.6 M undefined
2009148.3 M undefined48.8 M undefined32.8 M undefined
2008139.6 M undefined44.4 M undefined30.2 M undefined
2007123 M undefined35 M undefined26.7 M undefined
2006108.4 M undefined26.9 M undefined18.3 M undefined
200593 M undefined20.3 M undefined12.6 M undefined
200479.6 M undefined14.7 M undefined9.2 M undefined
200365.9 M undefined12.8 M undefined7 M undefined

Meridian Bioscience stock margins

The Meridian Bioscience margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Meridian Bioscience. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Meridian Bioscience.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Meridian Bioscience's sales revenue. A higher gross margin percentage indicates that the Meridian Bioscience retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Meridian Bioscience's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Meridian Bioscience's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Meridian Bioscience's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Meridian Bioscience. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Meridian Bioscience's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Meridian Bioscience Margin History

Meridian Bioscience Gross marginMeridian Bioscience Profit marginMeridian Bioscience EBIT marginMeridian Bioscience Profit margin
2025e56.56 %7.61 %6.2 %
2024e56.56 %10.73 %8.6 %
2023e56.56 %15.97 %12.59 %
202256.56 %22.7 %12.75 %
202163.27 %32.03 %22.46 %
202061.57 %26.8 %18.21 %
201959.05 %19.35 %12.14 %
201861.33 %20.93 %11.14 %
201761.9 %22.31 %10.76 %
201664.86 %27.33 %16.42 %
201562.58 %28.8 %18.22 %
201462.08 %27.75 %18.38 %
201364.12 %30.37 %20.14 %
201263.12 %29.13 %19.34 %
201161.96 %26.32 %16.88 %
201062.03 %28.74 %18.6 %
200962.31 %32.91 %22.12 %
200861.96 %31.81 %21.63 %
200760.89 %28.46 %21.71 %
200659.69 %24.82 %16.88 %
200559.03 %21.83 %13.55 %
200457.41 %18.47 %11.56 %
200358.12 %19.42 %10.62 %

Meridian Bioscience Aktienanalyse

What does Meridian Bioscience do?

Meridian Bioscience Inc. is a global company specializing in the development, manufacture, and distribution of test kits for the diagnosis of infectious diseases and other medical conditions. The company was founded in 1976 by William J. Motto and initially focused on the development of enzyme immunoassays (EIA). Over the years, the company has grown and diversified its product offerings, becoming a leading provider of diagnostic test kits for acute and chronic medical conditions, infectious diseases, gastrointestinal infections, and virology. The company's success is attributed to its diverse range of test kits in various medical areas, including immunology, infectious diseases, sexually transmitted diseases, gastroenterology, and virology. Additionally, Meridian Bioscience Inc. stays up-to-date with the latest technological advancements in biotechnology to ensure the fast and effective performance of its tests. The company operates globally, collaborating with universities, research institutions, government agencies, and distributors to ensure the worldwide distribution and marketing of its products. In summary, Meridian Bioscience Inc. is an innovative company specializing in the development, manufacture, and distribution of test kits for the diagnosis of infectious diseases and other medical conditions. Its wide range of products, including immunology products, infectious disease diagnostics, sexually transmitted disease test kits, gastroenterology, virology, and molecular diagnostics, coupled with advanced technologies, provides fast, accurate, and reliable diagnostic support. Meridian Bioscience ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Meridian Bioscience's Sales Figures

The sales figures of Meridian Bioscience originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Meridian Bioscience’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Meridian Bioscience's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Meridian Bioscience’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Meridian Bioscience stock

How much revenue did Meridian Bioscience generate this year?

Meridian Bioscience has achieved a revenue of 302.36 M USD this year.

How much was the turnover of the company Meridian Bioscience compared to the previous year?

The revenue of Meridian Bioscience has increased by 2.8% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Meridian Bioscience?

The revenue of Meridian Bioscience is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Meridian Bioscience measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Meridian Bioscience so important for investors?

The revenue of Meridian Bioscience is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Meridian Bioscience pay?

Over the past 12 months, Meridian Bioscience paid a dividend of 0.13 USD . This corresponds to a dividend yield of about 0.37 %. For the coming 12 months, Meridian Bioscience is expected to pay a dividend of 0.24 USD.

What is the dividend yield of Meridian Bioscience?

The current dividend yield of Meridian Bioscience is 0.37 %.

When does Meridian Bioscience pay dividends?

Meridian Bioscience pays a quarterly dividend. This is distributed in the months of June, September, December, March.

How secure is the dividend of Meridian Bioscience?

Meridian Bioscience paid dividends every year for the past 3 years.

What is the dividend of Meridian Bioscience?

For the upcoming 12 months, dividends amounting to 0.24 USD are expected. This corresponds to a dividend yield of 0.7 %.

In which sector is Meridian Bioscience located?

Meridian Bioscience is assigned to the 'Health' sector.

Wann musste ich die Aktien von Meridian Bioscience kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Meridian Bioscience from 2/14/2019 amounting to 0.125 USD, you needed to have the stock in your portfolio before the ex-date on 2/1/2019.

When did Meridian Bioscience pay the last dividend?

The last dividend was paid out on 2/14/2019.

What was the dividend of Meridian Bioscience in the year 2023?

In the year 2023, Meridian Bioscience distributed 0 USD as dividends.

In which currency does Meridian Bioscience pay out the dividend?

The dividends of Meridian Bioscience are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Meridian Bioscience stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Meridian Bioscience

Our stock analysis for Meridian Bioscience Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Meridian Bioscience Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.